Drugs / Tablets, Oral, 100 mg, once daily (QD), upto 2 years
Tablets, Oral, 100 mg, once daily (QD), upto 2 years
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00754325 Comparator | Sep 2008 → Nov 2011 | female breast carcinoma | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tablets, Oral, 100 mg, once daily (QD), upto 2 years | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00754325 ↗ |
| Route | Oral | “Tablets, Oral, 100 mg, once daily (QD), upto 2 years” NCT00754325 ↗ |